comparemela.com

Latest Breaking News On - Hemispherian as - Page 1 : comparemela.com

Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics

/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.

United statesSteven powellPaul lelieveldChristen sveaasZeno albisserInvestor partnershipMeneldor coDutch investment firmWestern europeanHemispherian as

Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program

/PRNewswire/ Hemispherian AS ("Hemispherian or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer.

Adam robertsonZeno albisserEuropean innovation councilChief scientific officerHemispherian as

Hemispherian raises seed funding for novel cancer therapeutics

/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.

United statesSteven powellPaul lelieveldFrode vartdalZeno albisserWolfram eichnerMeneldor coDutch investment firmDallas hackMasha strWestern europeanHemispherian as

vimarsana © 2020. All Rights Reserved.